University of Eastern Piedmont   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Alessandria Italy (1998)

Organization Overview

First Clinical Trial
2006
NCT01757457
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

AO Maggiore della Carita | Azienda Ospedaliero Universitaria Maggiore della Carita | Eastern Piedmont University | Eastern Piedmont University, Novara, Italy | "Maggiore della Carità" Hospital, Novara | University of Eastern Piedmont | University of Eastern Piedmont, Novara - Maggiore della Carità Hospital, Novara

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Coronary Syndrome (Phase 4)

Amyotrophic Lateral Sclerosis (Phase 2)

Colic (Phase 4)

Diabetes Mellitus, Type 1 (Phase 3)

Infarction (Phase 4)

Insulin Resistance (Phase 4)

Motor Neuron Disease (Phase 2)

Myocardial Infarction (Phase 4)

Obesity (Phase 4)

Pediatric Obesity (Phase 4)

Sclerosis (Phase 2)

Stroke (Phase 4)

Syndrome (Phase 4)

Urinary Bladder Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 14
  • # of Trial APIs: 19